• Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23685455; PubMed=25538140).
  
• Mutation; HGNC; HGNC:1424; CAD; Simple; p.Arg1854Gln (c.5561G>A); ClinVar=VCV001481207; Zygosity=Heterozygous (PubMed=27350335).
  
• Mutation; HGNC; HGNC:3330; EML1; Simple; p.Arg64Trp (c.190C>T); Zygosity=Heterozygous (PubMed=27350335).
  
• Mutation; HGNC; HGNC:8761; PDCD10; Simple; p.Pro28Ser (c.82C>T); Zygosity=Homozygous (PubMed=27350335).
  
• Mutation; HGNC; HGNC:30400; SEMA3G; Simple; p.Arg300Cys (c.898C>T); Zygosity=Heterozygous (PubMed=27350335).
  

PubMed=23685455; DOI=10.1038/nature12154
Joanna Kaplon, Liang Zheng, Katrin Meissl, Barbara Chaneton, Vitaly A. Selivanov, Gillian Mackay, Sjoerd H. van der Burg, Elizabeth M.E. Verdegaal, Marta Cascante, Tomer Shlomi, Eyal Gottlieb, Daniel S. Peeper;
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
Nature 498:109-112(2013)

PubMed=25538140; DOI=10.15252/msb.20145450; PMCID=PMC4300494
Marjon A. Smit, Gianluca Maddalo, Kylie Greig, Linsey M. Raaijmakers, Patricia Abrao Possik, Bas van Breukelen, Salvatore Cappadona, Albert J.R. Heck, A.F. Maarten Altelaar, Daniel S. Peeper;
ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma.
Mol. Syst. Biol. 10:772-772(2014)

PubMed=27350335; DOI=10.1038/nature18945
Elizabeth M.E. Verdegaal, Noel F.C.C. de Miranda, Marten Visser, Tom Harryvan, Marit M. van Buuren, Rikke Sick Andersen, Sine Reker Hadrup, Caroline E. van der Minne, Remko Schotte, Hergen Spits, John B.A.G. Haanen ...Show all 14 authors... , Ellen H.W. Kapiteijn, Ton Nicolaas Schumacher, Sjoerd H. van der Burg; Show fewer authors
Neoantigen landscape dynamics during human melanoma-T cell interactions.
Nature 536:91-95(2016)